keyword
https://read.qxmd.com/read/38513576/ilc2s-unraveling-the-innate-immune-orchestrators-in-allergic-inflammation
#21
REVIEW
Hui-Fei Lu, Yi-Chi Zhou, Dan-Dan Luo, Dun-Hui Yang, Xi-Jia Wang, Bao-Hui Cheng, Xian-Hai Zeng
The prevalence rate of allergic diseases including asthma, atopic rhinitis (AR) and atopic dermatitis (AD) has been significantly increasing in recent decades due to environmental changes and social developments. With the study of innate lymphoid cells, the crucial role played by type 2 innate lymphoid cells (ILC2s) have been progressively unveiled in allergic diseases. ILC2s, which are a subset of innate lymphocytes initiate allergic responses. They respond swiftly during the onset of allergic reactions and produce type 2 cytokines, working in conjunction with T helper type 2 (Th2) cells to induce and sustain type 2 immune responses...
March 19, 2024: International Immunopharmacology
https://read.qxmd.com/read/38489062/safety-of-biological-therapies-for-severe-asthma-an-analysis-of-suspected-adverse-reactions-reported-in-the-who-pharmacovigilance-database
#22
JOURNAL ARTICLE
Paola Maria Cutroneo, Elena Arzenton, Fabiana Furci, Fabio Scapini, Maria Bulzomì, Nicoletta Luxi, Marco Caminati, Gianenrico Senna, Ugo Moretti, Gianluca Trifirò
BACKGROUND: The management of uncontrolled severe asthma has greatly improved since the advent of novel biologic therapies. Up to August 2022, five biologics have been approved for the type 2 asthma phenotype: anti-IgE (omalizumab), anti-IL5 (mepolizumab, reslizumab, benralizumab), and anti-IL4 (dupilumab) monoclonal antibodies. These drugs are usually well tolerated, although long-term safety information is limited, and some adverse events have not yet been fully characterized. Spontaneous reporting systems represent the cornerstone for the detection of potential signals and evaluation of the real-world safety of all marketed drugs...
March 15, 2024: BioDrugs: Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy
https://read.qxmd.com/read/38487467/house-dust-mite-sublingual-allergen-immunotherapy-tablet-is-safe-and-well-tolerated-in-dutch-clinical-practice
#23
JOURNAL ARTICLE
Žana Tempels-Pavlica, Mark C J Aarts, Paco M J Welsing, Akke-Nynke van der Meer, Leonard P van der Zwan, Elena Uss, André C Knulst
BACKGROUND: Half (49%) of clinically diagnosed allergic rhinitis (AR) patients are sensitized to house dust mite (HDM). If allergen avoidance and symptomatic medication fail, allergen immunotherapy may be indicated. OBJECTIVE: We investigated safety and tolerability of HDM-sublingual immunotherapy by HDM-SLIT tablets in Dutch daily clinical practice. METHODS: Daily intake of 12 SQ-HDM SLIT-tablet was investigated in a prospective, multicenter, observational study (EUPAS43753)...
2024: Front Allergy
https://read.qxmd.com/read/38486383/a-review-on-novel-therapeutic-modalities-and-evidence-based-drug-treatments-against-allergic-rhinitis
#24
JOURNAL ARTICLE
Bhupendra Sharma, Rohitas Deshmukh
Allergic rhinitis (AR) is an IgE-mediated atopic disease that occurs due to inhaled antigens in the immediate phase. Misdiagnosis, insufficient treatment, or no treatment at all are frequent problems associated with the widespread condition known as chronic allergic rhinitis. AR symptoms include runny, itchy, stuffy, and sneezing noses. Asthma and nasal polyps, for example, sometimes occur simultaneously in patients. In order for people living with AR to be as comfortable and productive as possible, treatment should center on reducing their symptoms...
March 14, 2024: Current Pharmaceutical Design
https://read.qxmd.com/read/38485910/a-quality-of-life-study-in-patients-with-anaphylaxis-to-hymenoptera-venom-in-iran
#25
JOURNAL ARTICLE
Mohammad Hasan Bemaniyan, Maryam Heidari, Marzieh Tavakol, Mohammad Nabavi, Fatemeh Ramezani Kashal, Maryam Gholami, Bita Bemaniyan
Little is known about the quality of life of patients with anaphylaxis to Hymenoptera venom. The Vespid Allergy Quality of Life Questionnaire (VQLQ) is commonly used to assess the psychological burden of this condition. This study aimed to evaluate the validity and reliability of the Persian version of VQLQ. In this cross-sectional study, VQLQ was translated into Persian according to expert recommendations.  The final translated version of VQLQ was then administered to 115 patients with Hymenoptera venom allergy at an asthma and allergy clinic in Iran...
February 11, 2024: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/38485909/baseline-severity-and-disease-duration-can-predict-the-response-to-allergen-specific-immunotherapy-in-allergic-rhinitis
#26
JOURNAL ARTICLE
Yan Li, Haiqing Xiao, Yinhui Zeng, Yiquan Tang, Lifeng Zhou, Wenlong Liu
Allergen-specific immunotherapy (AIT) has confirmed its efficacy in improving the symptoms of allergic rhinitis. However, no reliable biomarkers have been identified to predict the efficacy of AIT were found. We aimed to find clinical and immunological markers to predict efficacy in children after 2 years of sublingual immunotherapy (SLIT). A total of 285 children diagnosed with allergic rhinitis were recruited. The clinical efficacy was evaluated by comparing endpoint and baseline symptom and medication scores (SMS)...
February 11, 2024: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/38484839/leveraging-learning-systems-to-improve-quality-and-patient-safety-in-allergen-immunotherapy
#27
REVIEW
Alexandra E Conway, Chase Rupprecht, Priya Bansal, Irene Yuan, Ziwei Wang, Marcus S Shaker, Marylee Verdi, Joel Bradley
Adverse events occur in all fields of medicine, including allergy-immunology, in which allergen immunotherapy medical errors can cause significant harm. Although difficult to experience, such errors constitute opportunities for improvement. Identifying system vulnerabilities can allow resolution of latent errors before they become active problems. We review key aspects and frameworks of the medical error response, acknowledging the fundamental responsibility of clinical teams to learn from harm. Adverse event response comprises 4 major phases: (1) event recognition and reporting, (2) investigation (for which root cause analysis can be helpful), (3) improvement (inclusive of the plan-do-study-act cycle), and (4) communication and resolution...
March 12, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38482460/correlation-of-blomia-tropicalis-specific-immunoglobulin-epsilon-profiles-with-family-history-of-atopy-in-a-filipino-population
#28
JOURNAL ARTICLE
Chanie Y Patanindagat, Jamie Ezra B Tarun, Ryla Jasmine T Pajaro, Jhon Jerald D Pintucan, Patricia Nichole M Quilang, Maureen B Sabit, John Donnie A Ramos
BACKGROUND: House dust mites are the major source of indoor allergens in the tropical and subtropical regions with Blomia tropicalis (Bt) allergens as one of the leading causative agents of sensitization among patients from the tropics. Despite the clinical importance of Bt in various populations, its allergenicity remains unclear among Filipino allergic patients. OBJECTIVE: This study determined the sensitization profiles of allergic Filipinos against Bt allergens and its correlation with atopy...
March 2024: Asia Pacific Allergy
https://read.qxmd.com/read/38482456/biomarkers-in-allergen-immunotherapy-focus-on-eosinophilic-inflammation
#29
REVIEW
Chang-Keun Kim, Zak Callaway, Jin-Sung Park, Ruby Pawankar, Takao Fujisawa
Asthma and allergic rhinitis (AR) are 2 of the most common chronic inflammatory disorders and they appear to be on the rise. Current pharmacotherapy effectively controls symptoms but does not alter the underlying pathophysiology. Allergen immunotherapy (AIT) is an evidence-based therapy for asthma and AR and has been recognized as the only therapeutic method that actually modifies the allergic disease process. There is a lack of objective markers that accurately and reliably reflect the therapeutic benefits of AIT...
March 2024: Asia Pacific Allergy
https://read.qxmd.com/read/38479712/real-world-safety-experience-with-peanut-arachis-hypogaea-allergen-powder-dnfp-in-2-500-peanut-allergic-children
#30
JOURNAL ARTICLE
Michele Jara, Ekaterina Walker, Stephen Tilles, Aikaterini Anagnostou
No abstract text is available yet for this article.
March 11, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38479711/who-are-the-potential-patients-for-omalizumab-for-food-allergy
#31
JOURNAL ARTICLE
Hugh A Sampson, J Andrew Bird, David Fleischer, Wayne G Shreffler, Jonathan Spergel
No abstract text is available yet for this article.
March 11, 2024: Annals of Allergy, Asthma & Immunology
https://read.qxmd.com/read/38477953/mesenchymal-stem-cell-derived-exosome-an-interesting-nanocarrier-to-improve-allergen-specific-intranasal-immunotherapy
#32
JOURNAL ARTICLE
Sajad Dehnavi, Maryam Dadmanesh, Negin Hosseini Rouzbahani, Mahmood Karimi, Ali Asadirad, Mohammad Gholami, Khodayar Ghorban
Increasing the efficacy of allergen-specific intranasal immunotherapy (INIT) has recently been the main goal of several studies to establish this route as a safe delivery method through mucosal pathways. In this case, the present study evaluated the potential of INIT using ovalbumin (OVA)-loaded mesenchymal stromal/stem cell (MSC)-derived exosomes (Exo-OVA) in an allergic asthma mouse model. Together with control groups, sensitized Balb/c mice underwent intranasal immunotherapy with Exo-OVA (10 μg OVA per dose) for three consecutive weeks...
December 28, 2023: Iranian Journal of Allergy, Asthma, and Immunology
https://read.qxmd.com/read/38460304/dexamethasone-protects-against-asthma-via-regulating-hif-1%C3%AE-glycolysis-lactate-axis-and-protein-lactylation
#33
JOURNAL ARTICLE
Ning Chen, Qiu-Meng Xie, Si-Ming Song, Si-Nuo Guo, Yu Fang, Guang-He Fei, Hui-Mei Wu
PURPOSE: Asthma can not be eradicated till now and its control primarily relies on the application of corticosteroids. Recently, glycolytic reprogramming has been reportedly contributed to asthma, this study aimed to reveal whether the effect of corticosteroids on asthma control is related to their regulation of glycolysis and glycolysis-dependent protein lactylation. METHODS: Ovalbumin (OVA) aeroallergen was used to challenge mice and stimulate human macrophage cell line THP-1 following dexamethasone (DEX) treatment...
March 8, 2024: International Immunopharmacology
https://read.qxmd.com/read/38455467/innate-type-2-cytokines-from-immune-regulation-to-therapeutic-targets
#34
REVIEW
Hye Young Kim, Dongjin Jeong, Ji Hyung Kim, Doo Hyun Chung
The intricate role of innate type-2 cytokines in immune responses is increasingly acknowledged for its dual nature, encompassing both protective and pathogenic dimensions. Ranging from defense against parasitic infections to contributing to inflammatory diseases like asthma, fibrosis, and obesity, these cytokines intricately engage with various innate immune cells. This review meticulously explores the cellular origins of innate type-2 cytokines and their intricate interactions, shedding light on factors that amplify the innate type-2 response, including TSLP, IL-25, and IL-33...
February 2024: Immune Network
https://read.qxmd.com/read/38449018/initial-updosing-phase-of-oral-immunotherapy-improves-quality-of-life-and-psychological-burden-in-parents-of-children-with-food-allergy
#35
JOURNAL ARTICLE
Sanghee Shin, Sehun Jang, Jiwon Kim, Jeongmin Song, Seeun Park, Yeonghee Kim, Min Hee Lee, Hyun Mi Kim, Young Ran Choi, Minyoung Jung, Minji Kim, Ji Young Lee, Jihyun Baek, Sukyung Kim, Jihyun Kim, Kangmo Ahn
Background: Oral immunotherapy (OIT) can impose psychological burdens on patients and their parents due to the necessary preparations and repeated adverse reactions. Objective: To investigate changes in quality of life (QoL) and psychological burden in parents of children receiving OIT for food allergy (FA). Methods: Children aged 3-13 years with FA were enrolled. Parents were asked to fill out the Korean versions of the Food Allergy Quality of Life-Parental Burden (FAQL-PB), the Korean versions of the Food Allergy Quality of Life-Parental Form (K-FAQLQ-PF), the Korean versions of the Beck Anxiety Inventory (K-BAI), and the Korean version of the Patient Health Questionnaire-9 (PHQ-9) for depression before OIT (T1), after 2 months of updosing (T2), and after the end of the updosing phase (T3)...
March 1, 2024: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/38449016/oral-immunotherapy-with-sunflower-seed-butter-and-a-review-of-seed-allergy
#36
REVIEW
Carolyn H Baloh, Joyce T Hsu
Food allergy to seeds is increasingly more common, with sesame being the most prevalent. Allergy to other seeds, including sunflower, pumpkin, poppy, mustard, and flaxseed, have been reported. Diagnosing a seed allergy is challenging, with many seeds being hidden additives in processed foods and cross-reactive testing. Food labels in the United States are now required to indicate the presence of sesame but other seeds are not required. Oral immunotherapy (OIT) protocols for peanut, milk, and egg are clinically being extrapolated to other foods, including sesame and sunflower seed...
March 1, 2024: Allergy and Asthma Proceedings:
https://read.qxmd.com/read/38447787/exhaled-breath-analyses-for-bronchial-thermoplasty-in-severe-asthma-patients
#37
JOURNAL ARTICLE
Pieta C Wijsman, Annika W M Goorsenberg, Julia N S d'Hooghe, Els J M Weersink, Dominic W Fenn, Anke H Maitland van der Zee, Jouke T Annema, Paul Brinkman, Peter I Bonta
BACKGROUND: Bronchial thermoplasty (BT) is a bronchoscopic treatment for severe asthma. Although multiple trials have demonstrated clinical improvement after BT, optimal patient selection remains a challenge and the mechanism of action is incompletely understood. The aim of this study was to examine whether exhaled breath analysis can contribute to discriminate between BT-responders and non-responders at baseline and to explore pathophysiological insights of BT. METHODS: Exhaled breath was collected from patients at baseline and six months post-BT...
March 4, 2024: Respiratory Medicine
https://read.qxmd.com/read/38444991/the-saudi-initiative-for-asthma-2024-update-guidelines-for-the-diagnosis-and-management-of-asthma-in-adults-and-children
#38
JOURNAL ARTICLE
Mohamed Saad Al-Moamary, Sami A Alhaider, Riyad Allehebi, Majdy M Idrees, Mohammed O Zeitouni, Mohammed O Al Ghobain, Abdullah F Alanazi, Adel S Al-Harbi, Abdullah A Yousef, Hassan S Alorainy, Mohamed S Al-Hajjaj
The Saudi Initiative for Asthma 2024 (SINA-2024) is the sixth version of asthma guidelines for the diagnosis and management of asthma for adults and children that was developed by the SINA group, a subsidiary of the Saudi Thoracic Society. The main objective of the SINA is to have guidelines that are up-to-date, simple to understand, and easy to use by healthcare workers dealing with asthma patients. To facilitate achieving the goals of asthma management, the SINA Panel approach is mainly based on the assessment of symptom control and risk for both adults and children...
2024: Annals of Thoracic Medicine
https://read.qxmd.com/read/38442583/bergapten-inhibits-airway-inflammation-and-mrgprx2-mediated-mast-cells-activation-by-targeting-nr4a1
#39
JOURNAL ARTICLE
Jue Wang, Yuanyuan Wu, Xiao Li, Xinghui Wang, Shuanying Yang
Asthma is a serious global health problem affecting 300 million persons around the world. Mast cells (MCs) play a major role in airway hyperresponsiveness (AHR) and inflammation in asthma, their exact effector mechanisms remain unclear. Here, we aim to investigate the inhibitory effect of Bergapten (BER) on MRGPRX2-mediated MCs activation through asthma model. Mouse model of asthma was established to examine the anti-asthmatic effects of BER. Calcium (Ca2+ ) influx, β-hexosaminidase and histamine release were used to assess MCs degranulation in vitro...
March 4, 2024: International Immunopharmacology
https://read.qxmd.com/read/38442574/linc00158-modulates-the-function-of-beas-2b-cells-via-targeting-bcl11b-and-ameliorates-ova-lps-induced-severe-asthma-in-mice-models
#40
JOURNAL ARTICLE
Zhengdao Mao, Yan Qian, Zhiguang Liu, Yujia Shi, Liang Fan, Qian Zhang
Persistent type (T) 2 airway inflammation plays an important role in the development of severe asthma. However, the molecular mechanisms leading to T2 severe asthma have yet to be fully clarified. Human normal lung epithelial cells (BEAS-2B cells) were transfected with LINC00158/BCL11B plasmid/small interfering RNA (siRNA). Levels of epithelial-mesenchymal transition (EMT)-related markers were measured using real-time qPCR (RT-qPCR) and western blot. A dual luciferase reporter assay was used to validate the targeting relationship between LINC00158 and BCL11B...
March 4, 2024: International Immunopharmacology
keyword
keyword
15390
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.